SCHEMBL18758665

SCHEMBL18758665

Bc1cc2c(=O)cc(C(=O)OCC)[nH]c2c(B)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
ALOX15 P16050 2/20 0.42
GPR35 Q9HC97 1/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 6/20 0.39
HPGD P15428 4/20 0.39
HSD17B10 Q99714 2/20 0.39
POLB P06746 2/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 3/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 3/20 0.38
GAA P10253 3/20 0.38
LMNA P02545 3/20 0.38
GLA P06280 2/20 0.38
MEN1 O00255 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18758669 0.81 ALOX15 (0.43) CDK1CCNB1ALOX15ALDH1A1KDM4E
SCHEMBL18758774 0.80 GPR35 (0.54) ALOX15GPR35ALDH1A1KDM4EHPGD
SCHEMBL11640545 0.78 GPR35 (0.64) CDK1CCNB1ALOX15GPR35ALDH1A1
SCHEMBL11190882 0.74 CDK1 (0.70) CDK1CCNB1ALOX15ALDH1A1KDM4E
SCHEMBL11180617 0.71 GAA (0.54) CDK1CCNB1ALDH1A1KDM4EHPGD
SCHEMBL10478330 0.71 ALOX15 (0.49) CDK1CCNB1ALOX15ALDH1A1KDM4E
SCHEMBL5639156 0.70 ALOX15 (0.69) ALOX15ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL11198920 0.70 ALOX15 (0.65) ALOX15ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24190132 0.69 CDK1 (0.48) CDK1CCNB1ALOX15ALDH1A1KDM4E
SCHEMBL30402891 0.69 CDK1 (0.48) CDK1CCNB1ALOX15ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017065899-A1 DEUTERATED CHLOROKYNURENINES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS AUSPEX PHARMACEUTICALS, INC. (US) 2017-04-20 WO disclosed